HITK: Summary for Hi-Tech Pharmacal Co., Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:57am EST - Canadian Markets open in 2 hours and 33 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Hi Tech Pharmacal Co. Inc. (HITK)

On Feb 9: 20.46 USD 0.00 (0.00%)

MORE ON HITK

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Hi-Tech Pharmacal Co., Inc. (NasdaqNM:HITK) Delayed quote data

Last Trade:	20.46 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	20.46
Open:	N/A
Bid:	N/A
Ask:	25.87 x 100
1y Target Est:	23.00

Day's Range:	N/A - N/A
52wk Range:	4.50 - 29.89
Volume:	0
Avg Vol (3m):	397,503
Market Cap:	247.18M
P/E (ttm):	10.30
EPS (ttm):	1.99
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add HITK to Portfolio

Download Data

HEADLINES

•	Hi-Tech Pharmacal Enters Oversold Territory
	Zacks.com (Wed, Jan 27)

•	Five Small-Cap Stocks to Own Now
	at TheStreet.com (Wed, Jan 20)

•	Why This Stock Is a Winner
	at Motley Fool (Tue, Jan 12)

•	Lightning Round OT: Immunogen, Synchronoss Tech and More
	at CNBC (Fri, Jan 8)

•	Hi-Tech Pharmacal says FDA clears Tropazone lotion
	AP (Thu, Jan 7)

•	Hi-Tech Pharmacals ECR Subsidiary to Launch a New Dermatitis Treatment
	Business Wire (Thu, Jan 7)

•	Hi-Tech Pharmacal Charts: Time to Get In
	at TheStreet.com (Mon, Jan 4)

•	Bristow Group (BRS): Zacks Rank Buy
	Zacks.com (Mon, Jan 4)

•	Generic-Drug Firms Prosper Amid Drive To Cut Health Costs
	Investor's Business Daily (Wed, Dec 30)

•	Five Stocks to Bank On in 2010
	at TheStreet.com (Wed, Dec 30)

•	5 Stocks Geared for Growth
	at Motley Fool (Wed, Dec 30)

•	Zacks Releases Four Powerful ''Buy'' Stocks: Hi-Tech Pharmacal Co, T. Rowe Price Group, Inc., Solarfun Power Holdings Co. and Maidenform Brands Inc.
	Zacks.com (Tue, Dec 29)

•	Hi-Tech Pharmacal Co. (HITK): Zacks Rank Buy
	Zacks.com (Tue, Dec 29)

•	According To Credit Suisse Vice President, Certain Health Care Stocks To Benefit Greatly From U.S. Legislation: Which Companies Stand To Benefit The Most?
	Wall Street Transcript (Mon, Dec 21)

More Headlines for HITK...

ANALYST

EPS Est (next year) (Apr-10) :	2.27
EPS Est (in 2 years) (Apr-11) :	1.65
Avg Rec (current)*:	4.0
PEG Ratio:	0.85

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•